MorphoSys' Management team hosted a conference call and webcast on July 29, 2021 at 2:00pm CEST (1:00pm GMT; 8:00am EDT) to present results for the Second Quarter and First Half 2021 and provide an outlook for 2021.
Here you can find a replay of the webcast.
<p>Dr. Jean-Paul Kress (CEO) presents the Company at the JMP Securities Hematology Summit on Wednesday, December 16, 2020, 10:30am ET (04:30pm CET).</p>
<p> </p>
You are now leaving the MorphoSys.com website. This link will take you to a different website. You are solely responsible for your interactions with that website.
Do you wish to proceed ?
Are you a U.S. resident? This portion of the MorphoSys website is intended for U.S. residents only. It is not for individuals living in Germany or other European Union member states.
Do you wish to proceed ?
MorphoSys is providing the data presented at medical congresses as part of scientific exchange. The scientific information may include data/information on investigational use(s) of compounds/drugs of which the efficacy and safety have not yet been established. Information available on this website is not intended to promote or otherwise commercialize (directly or indirectly) any off-label or unapproved uses of MorphoSys’ products. Copies of congress presentations may not be reproduced without written permission from the congress and the authors.
Are you a U.S. resident? This portion of the MorphoSys website is intended for U.S. residents only. It is not for individuals living in Germany or other European Union member states.